AR Baltic Medical: Advancing Patient-Centered Technologies

​

Founded in 2006 in Vilnius, Lithuania, AR Baltic Medical is a manufacturer of medical devices, with a focus on drug-coated balloon catheters. Our aim is to support healthcare professionals by providing medical technologies designed to meet a wide range of clinical needs.

Our mission:
To support physicians and patients by delivering high-quality devices intended for effective treatment.

Our CE-marked drug-coated balloon platform is designed for the treatment of fibrotic and atherosclerotic strictures.

These pathologies occur across a variety of anatomical regions. Applications currently in use or under clinical investigation include:​

• Intra-cranial applications

• Supra-aortic applications

• Peripheral applications

• Coronary arteries

• Veins & Dialytic AV Fistulas

• Urethra and Ureter applications*

• Benign Prostatic Hyperplasia (BPH) Treatment*

 

​(*Note: Use in Urethra and Ureter applications as well as for BPH may be investigational and subject to clinical evaluation and regulatory approval in the relevant region.)

​

Drug-Coating Technology
Our drug-coated balloon catheters are designed with a proprietary coating that combines Paclitaxel and Dextran, intended to improve drug delivery and therapeutic performance during treatment. The specific formulation is developed to support consistent coating transfer to the target tissue.

Design Considerations
AR Baltic Medical emphasizes product design features such as a low-profile balloon catheter, intended to support ease of navigation and placement during procedures, while aiming to minimize trauma and enhance procedural control.

Expanding Use Beyond Intravascular Applications
In addition to vascular use, our products are under evaluation or development for selected non-vascular indications, including the urethra, ureter, and prostatic tissue. These applications are being assessed according to clinical evidence and applicable regulatory pathways.

​

Sales and Distribution

AR Baltic Medical UAB is a manufacturer of medical devices, including CE-marked products compliant with the European Medical Device Regulation (EU) 2017/745. The company sells its products exclusively through authorized and qualified distributors, or in response to individual, unsolicited requests from licensed healthcare professionals. AR Baltic Medical does not participate directly in public tenders, hospital procurement procedures, or marketing campaigns.

In non-EU countries, AR Baltic Medical supplies products that are authorized under the respective local regulatory frameworks. The marketing, distribution, and promotion in both EU and non-EU countries are the sole responsibility of the local distributor, in accordance with applicable national laws and regulations.

​

Market Access and Competition Policy

At AR Baltic Medical, we may appoint exclusive or sole distributors for certain products in specific countries or territories. However, such appointments do not prevent other authorized and qualified distributors from supplying the same products in those markets.

We are firmly committed to supporting and complying with the principles of the free movement of goods and fair competition. This includes adherence to applicable laws and regulations such as Articles 34–36, 101, and 102 of the Treaty on the Functioning of the European Union (TFEU), Regulation (EC) No 1/2003, the Sherman Act (1890), Clayton Act (1914), FTC Act (1914), the UK Competition Act 1998, Enterprise Act 2002, the German Gesetz gegen Wettbewerbsbeschränkungen (GWB), and the French Code de commerce (Livre IV).